Accelerating precision oncology with artificial intelligence

Precision oncology is a revolution in cancer care that matches the right treatments to patients, and applying artificial intelligence and machine learning to clinical, genomic, and social determinants of health data can help develop targeted prevention strategies and new treatments while identifying eligible patients.

pharmexec.com

Relevant topic timeline:

8/22/2023

Scientists employ AI to predict brain cancer outcomes

Researchers at Stanford Medicine and their colleagues have developed an artificial intelligence model that uses stained images of glioblastoma tissue to predict the aggressiveness of the brain tumor, determine the genetic makeup of the tumor cells, and evaluate whether cancerous cells remain after surgery.

8/29/2023

The company landscape for artificial intelligence in large-molecule drug discovery

Artificial intelligence (AI) techniques, particularly machine learning, are increasingly being used in drug research and development (R&D), with applications expanding beyond small molecules to include large-molecule modalities such as antibodies, gene therapies, and RNA-based therapies. These therapies, which make up a significant portion of the biopharma industry's current and future commercial potential, are expected to represent approximately 50% of the oncology market by revenue in 2030, with the majority coming from antibodies.

9/5/2023

New AI technology tool aids doctors in diagnosing prostate cancer

UF Health in Jacksonville is using artificial intelligence to help doctors diagnose prostate cancer, allowing them to evaluate cases more quickly and accurately. The AI technology, provided by Paige Prostate, assists in distinguishing between benign and malignant tissue, enhancing doctors' abilities without replacing them.

9/7/2023

Microsoft and Paige are building the world's largest AI model for detecting cancer

Microsoft is partnering with digital pathology provider Paige to develop the world's largest image-based AI model for identifying cancer, which can identify both common and rare cancers and aims to assist doctors in dealing with staffing shortages and growing caseloads. Paige has received FDA approval for its AI viewing tool FullFocus, and with Microsoft's help, it has built an advanced AI model that is training on 4 million slides, making it the largest computer vision model publicly announced. The model aims to improve accuracy and efficiency in pathology and democratize access to healthcare.

9/18/2023

Feinstein Institutes Awarded $3.1M to Develop AI Tools for Hospital Patient Risk Monitoring

Scientists at The Feinstein Institutes for Medical Research have been awarded $3.1 million to develop artificial intelligence and machine learning tools to monitor hospitalized patients and predict deterioration, aiming to improve patient outcomes.

9/22/2023

AI Speeds Up Patient Recruitment and Reduces Costs of Clinical Drug Trials

Major drugmakers are using artificial intelligence (AI) to accelerate drug development by quickly finding patients for clinical trials and reducing the number of participants needed, potentially saving millions of dollars. AI is increasingly playing a substantial role in human drug trials, with companies such as Amgen, Bayer, and Novartis using AI tools to scan vast amounts of medical data and identify suitable trial patients, significantly reducing the time and cost of recruitment. The use of AI in drug development is on the rise, with the US FDA receiving over 300 applications that incorporate AI or machine learning in drug development from 2016 through 2022.

Topics

Posted 8/24/2023, 7:21:49 PM